Cepheid Share Price

Stocks

01/12/01

15/17/15	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/16/05	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/16/27	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/16/24	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/16/06	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/16/06	Danaher : renforce dans les diagnostics avec Cepheid
06/16/06	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
SARTORIUS AG	+2.01%	+5.95%	+36.00%	-16.72%	1.83TCr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-1.91%	-6.43%	-38.99%	+25.26%	184.91Cr
ECKERT & ZIEGLER SE	+3.12%	+1.54%	-27.75%	+20.13%	87Cr
VAREX IMAGING CORPORATION	+0.05%	-0.05%	+53.07%	-2.43%	78Cr
QUIDELORTHO CORPORATION	-1.01%	-0.28%	-61.77%	-84.93%	75Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	-0.96%	+2.71%	-29.98%	-47.48%	69Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-4.53%	-1.61%	-42.90%	-53.34%	59Cr
908 DEVICES INC.	+1.92%	+7.17%	+45.57%	+81.62%	47Cr
CELLAVISION AB	-1.26%	+3.48%	-0.92%	+8.28%	42Cr
Average	-0.26%	+1.79%	-7.52%	-7.73%	274.61Cr
Weighted average by Cap.	+1.31%	+4.26%	+21.56%	-13.33%